Exact Mass: 968.5924

Exact Mass Matches: 968.5924

Found 22 metabolites which its exact mass value is equals to given mass value 968.5924, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PI(22:3(10Z,13Z,16Z)/20:3(6,8,11)-OH(5))

[(2R)-2-{[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]oxy}-3-[(10Z,13Z,16Z)-tricosa-10,13,16-trienoyloxy]propoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid

C52H89O14P (968.599)


PI(22:3(10Z,13Z,16Z)/20:3(6,8,11)-OH(5)) is an oxidized phosphatidylinositol (PI). Phosphatidylinositols are important lipids, both as a key membrane constituent and as a participant in essential metabolic processes, both directly and via a number of metabolites. Phosphatidylinositols are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to inositol (hexahydroxycyclohexane). Phosphatidylinositols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PI(22:3(10Z,13Z,16Z)/20:3(6,8,11)-OH(5)), in particular, consists of one chain of 10Z,13Z,16Z-docosenoyl at the C-1 position and one chain of 5-hydroxyeicosatetrienoyl at the C-2 position. The inositol group that is part of every phosphatidylinositol lipid is covalently linked to the phosphate group that acts as a bridge to the lipid tail. In most organisms, the stereochemical form of this inositol is myo-D-inositol (with one axial hydroxyl in position 2 with the remainder equatorial), although other forms can be found in certain plant phosphatidylinositols. Phosphatidylinositol is especially abundant in brain tissue, where it can amount to 10\\% of the phospholipids, but it is present in all tissues and cell types. There is usually less of it than of phosphatidylcholine, phosphatidylethanolamine and phosphatidylserine. In animal tissues, phosphatidylinositol is the primary source of the arachidonic acid required for biosynthesis of eicosanoids, including prostaglandins, via the action of the enzyme phospholipase A2. Phosphatidylinositol can be phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated by a specific kinase. Seven different isomers are known, but the most important in both quantitative and biological terms are phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PIs composed exclusively of non-phosphorylated inositol exhibit a net charge of -1 at physiological pH. Molecules with phosphorylated inositol (such as PIP, PIP2, PIP3, etc.) are termed polyphosphoinositides. The polyphosphoinositides are important intracellular transducers of signals emanating from the plasma membrane. The synthesis of PI involves CDP-activated 1,2-diacylglycerol condensation with myo-inositol.

   

PI(20:3(6,8,11)-OH(5)/22:3(10Z,13Z,16Z))

[(2R)-3-{[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]oxy}-2-[(10Z,13Z,16Z)-tricosa-10,13,16-trienoyloxy]propoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid

C52H89O14P (968.599)


PI(20:3(6,8,11)-OH(5)/22:3(10Z,13Z,16Z)) is an oxidized phosphatidylinositol (PI). Phosphatidylinositols are important lipids, both as a key membrane constituent and as a participant in essential metabolic processes, both directly and via a number of metabolites. Phosphatidylinositols are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to inositol (hexahydroxycyclohexane). Phosphatidylinositols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PI(20:3(6,8,11)-OH(5)/22:3(10Z,13Z,16Z)), in particular, consists of one chain of 5-hydroxyeicosatetrienoyl at the C-1 position and one chain of 10Z,13Z,16Z-docosenoyl at the C-2 position. The inositol group that is part of every phosphatidylinositol lipid is covalently linked to the phosphate group that acts as a bridge to the lipid tail. In most organisms, the stereochemical form of this inositol is myo-D-inositol (with one axial hydroxyl in position 2 with the remainder equatorial), although other forms can be found in certain plant phosphatidylinositols. Phosphatidylinositol is especially abundant in brain tissue, where it can amount to 10\\% of the phospholipids, but it is present in all tissues and cell types. There is usually less of it than of phosphatidylcholine, phosphatidylethanolamine and phosphatidylserine. In animal tissues, phosphatidylinositol is the primary source of the arachidonic acid required for biosynthesis of eicosanoids, including prostaglandins, via the action of the enzyme phospholipase A2. Phosphatidylinositol can be phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated by a specific kinase. Seven different isomers are known, but the most important in both quantitative and biological terms are phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PIs composed exclusively of non-phosphorylated inositol exhibit a net charge of -1 at physiological pH. Molecules with phosphorylated inositol (such as PIP, PIP2, PIP3, etc.) are termed polyphosphoinositides. The polyphosphoinositides are important intracellular transducers of signals emanating from the plasma membrane. The synthesis of PI involves CDP-activated 1,2-diacylglycerol condensation with myo-inositol.

   

PC(20:2(11Z,14Z)/LTE4)

(2-{[(2R)-2-{[(2R)-2-amino-3-{[(4S,5R,6E,8E,10Z,13Z)-1-carboxy-4-hydroxynonadeca-6,8,10,13-tetraen-5-yl]sulfanyl}propanoyl]oxy}-3-[(11Z,14Z)-icosa-11,14-dienoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium

C51H89N2O11PS (968.5924)


PC(20:2(11Z,14Z)/LTE4) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:2(11Z,14Z)/LTE4), in particular, consists of one chain of one 11Z,14Z-eicosadienoyl at the C-1 position and one chain of Leukotriene E4 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

   

PC(LTE4/20:2(11Z,14Z))

(2-{[(2R)-3-{[(2R)-2-amino-3-{[(4S,5R,6E,8E,10Z,13Z)-1-carboxy-4-hydroxynonadeca-6,8,10,13-tetraen-5-yl]sulphanyl}propanoyl]oxy}-2-[(11Z,14Z)-icosa-11,14-dienoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C51H89N2O11PS (968.5924)


PC(LTE4/20:2(11Z,14Z)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(LTE4/20:2(11Z,14Z)), in particular, consists of one chain of one Leukotriene E4 at the C-1 position and one chain of 11Z,14Z-eicosadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

   
   

versipelostatin D

versipelostatin D

C55H84O14 (968.5861)


   

Dolastatin 12

Dolastatin 12

C50H80N8O11 (968.5946)


A natural product found in Leptolyngbya speciesRS03.

   
   

PC(20:2(11Z,14Z)/LTE4)

PC(20:2(11Z,14Z)/LTE4)

C51H89N2O11PS (968.5924)


   

PC(LTE4/20:2(11Z,14Z))

PC(LTE4/20:2(11Z,14Z))

C51H89N2O11PS (968.5924)


   

PI(22:3(10Z,13Z,16Z)/20:3(6,8,11)-OH(5))

PI(22:3(10Z,13Z,16Z)/20:3(6,8,11)-OH(5))

C52H89O14P (968.599)


   

PI(20:3(6,8,11)-OH(5)/22:3(10Z,13Z,16Z))

PI(20:3(6,8,11)-OH(5)/22:3(10Z,13Z,16Z))

C52H89O14P (968.599)


   

Dgdg O-22:6_18:5

Dgdg O-22:6_18:5

C55H84O14 (968.5861)


   

Dgdg O-18:5_22:6

Dgdg O-18:5_22:6

C55H84O14 (968.5861)


   
   

(8r,14s,17s,25r,28r,29s)-17-benzyl-2-[(2s)-butan-2-yl]-28-ethyl-3,9,18,26-tetrahydroxy-14-isopropyl-7,13,16,20,22,22,24,25,29-nonamethyl-8-(2-methylpropyl)-1-oxa-4,7,10,13,16,19,24,27-octaazacyclotriaconta-3,9,18,26-tetraene-6,12,15,21,23,30-hexone

(8r,14s,17s,25r,28r,29s)-17-benzyl-2-[(2s)-butan-2-yl]-28-ethyl-3,9,18,26-tetrahydroxy-14-isopropyl-7,13,16,20,22,22,24,25,29-nonamethyl-8-(2-methylpropyl)-1-oxa-4,7,10,13,16,19,24,27-octaazacyclotriaconta-3,9,18,26-tetraene-6,12,15,21,23,30-hexone

C50H80N8O11 (968.5946)


   

(8s,14s,17s,20s,25s)-17-benzyl-28-ethyl-3,9,18,26-tetrahydroxy-14-isopropyl-7,13,16,20,22,22,24,25,29-nonamethyl-8-(2-methylpropyl)-2-(sec-butyl)-1-oxa-4,7,10,13,16,19,24,27-octaazacyclotriaconta-3,9,18,26-tetraene-6,12,15,21,23,30-hexone

(8s,14s,17s,20s,25s)-17-benzyl-28-ethyl-3,9,18,26-tetrahydroxy-14-isopropyl-7,13,16,20,22,22,24,25,29-nonamethyl-8-(2-methylpropyl)-2-(sec-butyl)-1-oxa-4,7,10,13,16,19,24,27-octaazacyclotriaconta-3,9,18,26-tetraene-6,12,15,21,23,30-hexone

C50H80N8O11 (968.5946)


   

16,26-diethyl-21,31-dihydroxy-11-({4-hydroxy-5-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-14-(hydroxymethyl)-3,4,6,10,12,18,24-heptamethyl-30-oxapentacyclo[26.2.1.0¹,⁶.0¹⁷,²⁶.0²⁰,²⁵]hentriaconta-4,15,18,28(31)-tetraene-23,27,29-trione

16,26-diethyl-21,31-dihydroxy-11-({4-hydroxy-5-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-14-(hydroxymethyl)-3,4,6,10,12,18,24-heptamethyl-30-oxapentacyclo[26.2.1.0¹,⁶.0¹⁷,²⁶.0²⁰,²⁵]hentriaconta-4,15,18,28(31)-tetraene-23,27,29-trione

C55H84O14 (968.5861)


   

17-benzyl-28-ethyl-3,9,18,26-tetrahydroxy-14-isopropyl-7,13,16,20,22,22,24,25,29-nonamethyl-8-(2-methylpropyl)-2-(sec-butyl)-1-oxa-4,7,10,13,16,19,24,27-octaazacyclotriaconta-3,9,18,26-tetraene-6,12,15,21,23,30-hexone

17-benzyl-28-ethyl-3,9,18,26-tetrahydroxy-14-isopropyl-7,13,16,20,22,22,24,25,29-nonamethyl-8-(2-methylpropyl)-2-(sec-butyl)-1-oxa-4,7,10,13,16,19,24,27-octaazacyclotriaconta-3,9,18,26-tetraene-6,12,15,21,23,30-hexone

C50H80N8O11 (968.5946)


   

(1s,3r,6r,10r,11r,12r,14r,15e,17s,20s,21s,24r,25s,26s)-16,26-diethyl-21,31-dihydroxy-11-{[(2r,4s,5s,6r)-4-hydroxy-5-{[(2s,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-14-(hydroxymethyl)-3,4,6,10,12,18,24-heptamethyl-30-oxapentacyclo[26.2.1.0¹,⁶.0¹⁷,²⁶.0²⁰,²⁵]hentriaconta-4,15,18,28(31)-tetraene-23,27,29-trione

(1s,3r,6r,10r,11r,12r,14r,15e,17s,20s,21s,24r,25s,26s)-16,26-diethyl-21,31-dihydroxy-11-{[(2r,4s,5s,6r)-4-hydroxy-5-{[(2s,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-14-(hydroxymethyl)-3,4,6,10,12,18,24-heptamethyl-30-oxapentacyclo[26.2.1.0¹,⁶.0¹⁷,²⁶.0²⁰,²⁵]hentriaconta-4,15,18,28(31)-tetraene-23,27,29-trione

C55H84O14 (968.5861)


   

(2s,8s,14s,17s,20s,25s,28r,29s)-17-benzyl-2-[(2s)-butan-2-yl]-28-ethyl-3,9,18,26-tetrahydroxy-14-isopropyl-7,13,16,20,22,22,24,25,29-nonamethyl-8-(2-methylpropyl)-1-oxa-4,7,10,13,16,19,24,27-octaazacyclotriaconta-3,9,18,26-tetraene-6,12,15,21,23,30-hexone

(2s,8s,14s,17s,20s,25s,28r,29s)-17-benzyl-2-[(2s)-butan-2-yl]-28-ethyl-3,9,18,26-tetrahydroxy-14-isopropyl-7,13,16,20,22,22,24,25,29-nonamethyl-8-(2-methylpropyl)-1-oxa-4,7,10,13,16,19,24,27-octaazacyclotriaconta-3,9,18,26-tetraene-6,12,15,21,23,30-hexone

C50H80N8O11 (968.5946)


   

(2s,8s,14s,17s,25s,28r,29s)-17-benzyl-2-[(2s)-butan-2-yl]-28-ethyl-3,9,18,26-tetrahydroxy-14-isopropyl-7,13,16,20,22,22,24,25,29-nonamethyl-8-(2-methylpropyl)-1-oxa-4,7,10,13,16,19,24,27-octaazacyclotriaconta-3,9,18,26-tetraene-6,12,15,21,23,30-hexone

(2s,8s,14s,17s,25s,28r,29s)-17-benzyl-2-[(2s)-butan-2-yl]-28-ethyl-3,9,18,26-tetrahydroxy-14-isopropyl-7,13,16,20,22,22,24,25,29-nonamethyl-8-(2-methylpropyl)-1-oxa-4,7,10,13,16,19,24,27-octaazacyclotriaconta-3,9,18,26-tetraene-6,12,15,21,23,30-hexone

C50H80N8O11 (968.5946)